Circulating N-terminal MUC1 (CA15-3) is used for monitoring the clinical course in breast cancer 21, and circulating MUC16 (CA125) is used for detecting early-stage disease and monitoring the clinical course in ovarian cancer 22. This evidence concerns the gene MUC16 and ovarian carcinoma.